H5N1 vaccines in humans.
Mariana Baz1, Catherine J Luke, Xing Cheng
1Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, MD, USA.
Virus Research
|June 4, 2013
Summary
Developing effective H5N1 influenza vaccines is crucial for pandemic preparedness. Strategies like using adjuvants and prime-boost methods enhance immune responses, offering a faster defense against emerging strains.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- Highly pathogenic avian H5N1 influenza viruses pose a significant pandemic threat.
- Rapid vaccine production and distribution pose challenges during a pandemic.
- Developing pre-pandemic vaccines is essential for rapid population protection.
Purpose of the Study:
- To review clinical trial data for various H5N1 influenza vaccines.
- To explore animal model studies on live attenuated vaccine reassortment.
- To assess strategies for improved immunogenicity and cross-protection.
Main Methods:
- Review of clinical trial data from H5N1 vaccine studies.
- Analysis of animal model studies on live attenuated vaccine reassortment.
- Evaluation of vaccine formulations with adjuvants and prime-boost strategies.
Main Results:
- Two doses of inactivated H5N1 vaccine are typically needed for licensure immunity.
- Adjuvants, particularly oil-in-water, reduce antigen requirements.
- Antibody titers can be boosted, and high titers correlate with cross-reactivity.
Conclusions:
- Adjuvant use and prime-boost strategies improve H5N1 vaccine immunogenicity.
- Further research is needed on live attenuated vaccine reassortment potential.
- Optimized H5N1 vaccines are vital for pandemic preparedness.
More Related Videos
Related Concept Videos
01:51Vaccinations
Overview
00:57Viral Recombination
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
01:27Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...